Penserra Capital Management LLC Spero Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$13.09 - $18.77 $9,555 - $13,702	-730 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.03 - $19.51 $716 - $1,073	55 Added 8.15%	730 $13,000
Q2 2021 Aug 12, 2021	BUY	$12.22 - $15.79 $672 - $868	55 Added 8.87%	675 $9,000
Q1 2021 May 13, 2021	SELL	$13.23 - $21.48 $66 - $107	-5 Reduced 0.8%	620 $9,000
Q4 2020 Feb 12, 2021	BUY	$11.65 - $22.07 $7,281 - $13,793	625 New	625 $12,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.